Multi-chain complexity solved: As investment products expand across different blockchains, reporting becomes increasingly complex for asset managers.
Automated data sourcing: Chainlink's CRE (Crypto Reporting Engine) automatically pulls and verifies NAV and performance data from:
- On-chain sources
- Centralized finance platforms
- Traditional financial systems
Pain point addressed: The solution eliminates manual reporting work that previously required tracking assets across multiple chains and platforms.
Verification built-in: All data is automatically verified, reducing errors and ensuring accuracy for compliance and investor reporting.
More products across more chains = more reporting complexity. @Chainlink鈥檚 CRE removes the pain, NAV + performance data auto-sourced and verified from on-chain, CeFi, and traditional systems.
Last week we announced our integration of聽@Chainlink Runtime Environment (CRE), here鈥檚 a closer look at what it unlocks for Enzyme Onyx 馃憞1/7 馃У
馃敡 Onyx Timing Strategy

**Enzyme Onyx** addresses different protocol needs across three key stages: - **Pre-TGE**: Early participation incentives to build community - **Post-TGE**: Strengthen Total Value Locked (TVL) after token launch - **Mature stage**: Manage liquidity across multiple assets including stablecoins and liquid staking tokens The platform provides structured, on-chain strategies that protocols can adopt when timing is right for their development phase. Each stage requires different tooling approaches, but most protocols eventually need comprehensive on-chain financial infrastructure. [Explore Onyx](https://enzyme.finance/products/onyx?utm_source=x&utm_medium=organic&utm_content=post)
Enzyme.Myso Introduces Institutional-Grade Options for On-Chain Yield Generation
Enzyme.Myso is advancing DeFi with institutional-grade on-chain options trading. The platform offers: - Native on-chain options strategies - Fully auditable transaction flows - Infrastructure designed for DAOs and institutions **Real-world implementation**: Compound DAO recently integrated covered calls into their treasury strategy using Enzyme.Myso, targeting approximately 15% APY while maintaining controlled risk exposure. This development signals a shift in how DAOs can optimize idle capital through sophisticated options strategies. *Learn more at* [Enzyme Finance](http://enzyme.finance/products/myso)
Tokenized Securities Market Projected to Reach $45T by 2030

Major financial institutions are forecasting significant growth in tokenized assets: - Citi projects tokenized securities market could reach $45T by 2030 - WEF estimates 10% of global GDP could be blockchain-tokenized by 2027 - McKinsey reports shift from pilot to at-scale deployment Key trends expected in next cycle: - Shift to natively tokenized funds - Increased institutional adoption - Integration with DeFi infrastructure - Clearer regulatory framework Traditional finance faces challenges from outdated systems, while tokenized vehicles offer programmability and global accessibility. Enzyme Protocol is positioning to support this transition with native tokenization capabilities. [Learn more about tokenized funds](http://enzyme.finance/use-cases/tokenized-funds)
Tokenized Real-World Assets Hit Major Milestone

Real-world assets (RWAs) tokenized on blockchain have reached a significant milestone, surpassing $10B in Total Value Locked (TVL). This marks a crucial shift in how traditional assets are being brought on-chain. Key developments: - Over $18B in assets now tokenized (excluding stablecoins) - Infrastructure development becoming priority for operational use - Integration possibilities include RWA funds, ETPs, and indices Enzyme Protocol enables users to leverage these tokenized assets within investment strategies, marking a practical step toward mainstream RWA adoption. Learn more about tokenized asset infrastructure: [Chainlink's Guide](https://blog.chain.link/definitive-guide-to-tokenized-assets/)